Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
67.33 USD | -0.13% | -0.16% | +16.47% |
Apr. 19 | Nephron Research Raises Boston Scientific's Price Target to $80 From $75 | MT |
Apr. 17 | FDA classifies recall of Boston Scientific device as 'most serious' | RE |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.47% | 99.1B | |
+2.64% | 207B | |
+1.80% | 175B | |
+8.59% | 132B | |
-3.42% | 60.89B | |
+12.71% | 52.04B | |
-6.61% | 45.48B | |
-4.53% | 38.81B | |
+9.27% | 38.77B | |
+3.97% | 26.09B |
- Stock Market
- Equities
- BSX Stock
- News Boston Scientific Corporation
- Transcript : Boston Scientific Corporation Presents at Bank of America 2022 Healthcare Conference, May-12-2022 08